Knowledge Center

Patent / Jan 11, 2024

Dry powder inhaler pharmaceutical composition of coated crystalline dry powder for inhalation

Authors:
  • Beatriz Fernandes
  • Filipe Vultos
  • Eunice Costa
Source:
WO 2024009079 A1

The present invention describes a dry powder inhaler pharmaceutical composition comprising one or more active pharmaceutical ingredients (API) coated with one or more force control agents (FCA) with optimized aerodynamic performance by micronizing crystalline API particles to the respirable range and coating the particles with a force control agent. The present invention also id pharmaceutical composition, and its use in medicine.

Ìý

Also in the Knowledge Center

Related Content

ËÄÉ«AV and Zerion Pharma create joint venture to further expand use of Dispersome® technology

Press Release / Oct 03, 2024
Article
View

API

ËÄÉ«AV inhalation grade APIs bring unique controlled performance to your formulation.

Page
Read more

Formulation

We develop inhalation & nasal products with our partners following Quality by Design principles to reach optimal product performance through robust processes.

Page
Read more